Global Sacral Nerve Stimulation 麻豆原创 Research Report 2024

Publication ID:

PB502247186

Publication Date:

March 4, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Sacral nerve stimulation (SNS) is a medical electrical stimulation therapy that is used to treat long-term bowel control and bladder control symptoms through the modulation of nerves controlling the lower urinary tract and pelvic floor.
The global Sacral Nerve Stimulation market was valued at US$ 742.6 million in 2023 and is anticipated to reach US$ 1586.1 million by 2030, witnessing a CAGR of 11.0% during the forecast period 2024-2030.
The external SNS device is one of the fastest growing product segments in the global sacral nerve stimulation market. Although there is just one external device available in the market, it is FDA approved and has the CE mark. However, this device is completely new to the market in APAC as implantable SNS devices are more popular compared with external SNS devices. With the introduction of new SNS devices by companies such as Nuvectra and Axonics Modulation Technologies, this segment is anticipated to have a positive outlook in the coming years.
This report aims to provide a comprehensive presentation of the global market for Sacral Nerve Stimulation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sacral Nerve Stimulation.
Report Scope
The Sacral Nerve Stimulation market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sacral Nerve Stimulation market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sacral Nerve Stimulation companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Medtronic
Boston Scientific
Abbott
Axonics Modulation Technologies
Nuvectra
Cogentix Medical
Cyberonics
Uroplasty, Inc
Neuropace
IntraPace, Inc
Codman & Shurtleff, Inc
Segment by Type
Implantable SNS
External SNS
Segment by Application
Hospitals
Clinics
ASCs
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sacral Nerve Stimulation companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Sacral Nerve Stimulation 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Implantable SNS
1.2.3 External SNS
1.3 麻豆原创 by Application
1.3.1 Global Sacral Nerve Stimulation 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 ASCs
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sacral Nerve Stimulation 麻豆原创 Perspective (2019-2030)
2.2 Sacral Nerve Stimulation Growth Trends by Region
2.2.1 Global Sacral Nerve Stimulation 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Sacral Nerve Stimulation Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Sacral Nerve Stimulation Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Sacral Nerve Stimulation 麻豆原创 Dynamics
2.3.1 Sacral Nerve Stimulation Industry Trends
2.3.2 Sacral Nerve Stimulation 麻豆原创 Drivers
2.3.3 Sacral Nerve Stimulation 麻豆原创 Challenges
2.3.4 Sacral Nerve Stimulation 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sacral Nerve Stimulation Players by Revenue
3.1.1 Global Top Sacral Nerve Stimulation Players by Revenue (2019-2024)
3.1.2 Global Sacral Nerve Stimulation Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Sacral Nerve Stimulation 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Sacral Nerve Stimulation Revenue
3.4 Global Sacral Nerve Stimulation 麻豆原创 Concentration Ratio
3.4.1 Global Sacral Nerve Stimulation 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sacral Nerve Stimulation Revenue in 2023
3.5 Sacral Nerve Stimulation Key Players Head office and Area Served
3.6 Key Players Sacral Nerve Stimulation Product Solution and Service
3.7 Date of Enter into Sacral Nerve Stimulation 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Sacral Nerve Stimulation Breakdown Data by Type
4.1 Global Sacral Nerve Stimulation Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Sacral Nerve Stimulation Forecasted 麻豆原创 Size by Type (2025-2030)
5 Sacral Nerve Stimulation Breakdown Data by Application
5.1 Global Sacral Nerve Stimulation Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Sacral Nerve Stimulation Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Sacral Nerve Stimulation 麻豆原创 Size (2019-2030)
6.2 North America Sacral Nerve Stimulation 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Sacral Nerve Stimulation 麻豆原创 Size by Country (2019-2024)
6.4 North America Sacral Nerve Stimulation 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Sacral Nerve Stimulation 麻豆原创 Size (2019-2030)
7.2 Europe Sacral Nerve Stimulation 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Sacral Nerve Stimulation 麻豆原创 Size by Country (2019-2024)
7.4 Europe Sacral Nerve Stimulation 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Sacral Nerve Stimulation 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific Sacral Nerve Stimulation 麻豆原创 Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Sacral Nerve Stimulation 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific Sacral Nerve Stimulation 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Sacral Nerve Stimulation 麻豆原创 Size (2019-2030)
9.2 Latin America Sacral Nerve Stimulation 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Sacral Nerve Stimulation 麻豆原创 Size by Country (2019-2024)
9.4 Latin America Sacral Nerve Stimulation 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sacral Nerve Stimulation 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa Sacral Nerve Stimulation 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Sacral Nerve Stimulation 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa Sacral Nerve Stimulation 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Medtronic
11.1.1 Medtronic Company Detail
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Sacral Nerve Stimulation Introduction
11.1.4 Medtronic Revenue in Sacral Nerve Stimulation Business (2019-2024)
11.1.5 Medtronic Recent Development
11.2 Boston Scientific
11.2.1 Boston Scientific Company Detail
11.2.2 Boston Scientific Business Overview
11.2.3 Boston Scientific Sacral Nerve Stimulation Introduction
11.2.4 Boston Scientific Revenue in Sacral Nerve Stimulation Business (2019-2024)
11.2.5 Boston Scientific Recent Development
11.3 Abbott
11.3.1 Abbott Company Detail
11.3.2 Abbott Business Overview
11.3.3 Abbott Sacral Nerve Stimulation Introduction
11.3.4 Abbott Revenue in Sacral Nerve Stimulation Business (2019-2024)
11.3.5 Abbott Recent Development
11.4 Axonics Modulation Technologies
11.4.1 Axonics Modulation Technologies Company Detail
11.4.2 Axonics Modulation Technologies Business Overview
11.4.3 Axonics Modulation Technologies Sacral Nerve Stimulation Introduction
11.4.4 Axonics Modulation Technologies Revenue in Sacral Nerve Stimulation Business (2019-2024)
11.4.5 Axonics Modulation Technologies Recent Development
11.5 Nuvectra
11.5.1 Nuvectra Company Detail
11.5.2 Nuvectra Business Overview
11.5.3 Nuvectra Sacral Nerve Stimulation Introduction
11.5.4 Nuvectra Revenue in Sacral Nerve Stimulation Business (2019-2024)
11.5.5 Nuvectra Recent Development
11.6 Cogentix Medical
11.6.1 Cogentix Medical Company Detail
11.6.2 Cogentix Medical Business Overview
11.6.3 Cogentix Medical Sacral Nerve Stimulation Introduction
11.6.4 Cogentix Medical Revenue in Sacral Nerve Stimulation Business (2019-2024)
11.6.5 Cogentix Medical Recent Development
11.7 Cyberonics
11.7.1 Cyberonics Company Detail
11.7.2 Cyberonics Business Overview
11.7.3 Cyberonics Sacral Nerve Stimulation Introduction
11.7.4 Cyberonics Revenue in Sacral Nerve Stimulation Business (2019-2024)
11.7.5 Cyberonics Recent Development
11.8 Uroplasty, Inc
11.8.1 Uroplasty, Inc Company Detail
11.8.2 Uroplasty, Inc Business Overview
11.8.3 Uroplasty, Inc Sacral Nerve Stimulation Introduction
11.8.4 Uroplasty, Inc Revenue in Sacral Nerve Stimulation Business (2019-2024)
11.8.5 Uroplasty, Inc Recent Development
11.9 Neuropace
11.9.1 Neuropace Company Detail
11.9.2 Neuropace Business Overview
11.9.3 Neuropace Sacral Nerve Stimulation Introduction
11.9.4 Neuropace Revenue in Sacral Nerve Stimulation Business (2019-2024)
11.9.5 Neuropace Recent Development
11.10 IntraPace, Inc
11.10.1 IntraPace, Inc Company Detail
11.10.2 IntraPace, Inc Business Overview
11.10.3 IntraPace, Inc Sacral Nerve Stimulation Introduction
11.10.4 IntraPace, Inc Revenue in Sacral Nerve Stimulation Business (2019-2024)
11.10.5 IntraPace, Inc Recent Development
11.11 Codman & Shurtleff, Inc
11.11.1 Codman & Shurtleff, Inc Company Detail
11.11.2 Codman & Shurtleff, Inc Business Overview
11.11.3 Codman & Shurtleff, Inc Sacral Nerve Stimulation Introduction
11.11.4 Codman & Shurtleff, Inc Revenue in Sacral Nerve Stimulation Business (2019-2024)
11.11.5 Codman & Shurtleff, Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Medtronic
Boston Scientific
Abbott
Axonics Modulation Technologies
Nuvectra
Cogentix Medical
Cyberonics
Uroplasty, Inc
Neuropace
IntraPace, Inc
Codman & Shurtleff, Inc

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.